Episode
Breakthrough RAS drug for cancer & Personalized mRNA vaccine for melanoma - News (Jun 3, 2026)
- Podcast
- The Automated Daily
- Published
- Jun 3, 2026
- Duration seconds
- 527
- Processing state
not_requested- Canonical source
- https://theautomateddaily.com/episodes/2026-06-03-breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma
Actions
POST https://stenobird.com/v1/public/podcasts/the-automated-daily-6466996/episodes/breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma-news-jun-3-2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-automated-daily-6466996/breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma-news-jun-3-2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Please support this podcast by checking out our sponsors: - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Breakthrough RAS drug for cancer - A major pancreatic cancer trial reports daraxonrasib, a broad RAS inhibitor, nearly doubled median survival—reviving hopes against long-"undruggable" targets like RAS and MYC. Personalized mRNA vaccine for melanoma - Five-year data suggest a personalized mRNA cancer vaccine plus Keytruda reduced melanoma recurrence and improved overall survival, strengthening the case for mRNA in oncology. New immunotherapy booster in lung cancer - A Scottish stage-four lung cancer patient describes meaningful tumor shrinkage in a trial of GRWD5769, a drug aimed at blocking cancer immune-escape and boosting immunotherapy response. Ultrasound wearable pacemaker progress - MIT researchers demonstrated a noninvasive, ultrasound-driven pacing approach using a small chest sticker and engineered heart cells, pointing toward surgery-free rhythm control for arrhythmias. Microsoft Majorana 2 quantum chip claims - Microsoft says its Majorana 2 quantum chip improves qubit stability dramatically, but scientists are asking for peer-reviewed evidence and clearer independent verification. AI worm risks from open models - University of Toronto researchers showcased a proof-of-concept "AI worm" that adapts across devices using open-weight models, raising urgent questions for cybersecurity and infrastructure defense. EU digital sovereignty push…